Eva Mezeiová

1.0k total citations
35 papers, 729 citations indexed

About

Eva Mezeiová is a scholar working on Pharmacology, Computational Theory and Mathematics and Molecular Biology. According to data from OpenAlex, Eva Mezeiová has authored 35 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pharmacology, 15 papers in Computational Theory and Mathematics and 14 papers in Molecular Biology. Recurrent topics in Eva Mezeiová's work include Cholinesterase and Neurodegenerative Diseases (23 papers), Computational Drug Discovery Methods (15 papers) and Chemical synthesis and alkaloids (8 papers). Eva Mezeiová is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (23 papers), Computational Drug Discovery Methods (15 papers) and Chemical synthesis and alkaloids (8 papers). Eva Mezeiová collaborates with scholars based in Czechia, Slovakia and Serbia. Eva Mezeiová's co-authors include Jan Korábečný, Ondřej Soukup, Kamil Kuča, Eugenie Nepovimová, Rafael Doležal, Katarína Špilovská, Daniel Jun, Martina Hrabinová, Jana Janočková and Lukáš Górecki and has published in prestigious journals such as Neuroscience, Molecules and European Journal of Medicinal Chemistry.

In The Last Decade

Eva Mezeiová

33 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Mezeiová Czechia 18 447 282 280 206 133 35 729
Ümide Demir Özkay Türkiye 20 298 0.7× 173 0.6× 447 1.6× 239 1.2× 161 1.2× 47 1.1k
Mohamed Benchekroun France 13 360 0.8× 221 0.8× 286 1.0× 171 0.8× 108 0.8× 18 626
Santosh Kumar Prajapati India 16 198 0.4× 126 0.4× 109 0.4× 178 0.9× 127 1.0× 39 546
María Isabel Fernández‐Bachiller Spain 11 753 1.7× 491 1.7× 443 1.6× 244 1.2× 279 2.1× 18 1.1k
Adrian Podkowa Poland 15 246 0.6× 98 0.3× 122 0.4× 210 1.0× 83 0.6× 23 642
Preet Anand India 10 680 1.5× 346 1.2× 566 2.0× 306 1.5× 244 1.8× 12 1.4k
Monika Marcinkowska Poland 17 216 0.5× 116 0.4× 187 0.7× 285 1.4× 128 1.0× 52 768
M. Victòria Clos Spain 19 934 2.1× 664 2.4× 486 1.7× 413 2.0× 385 2.9× 45 1.4k
Jakub Jończyk Poland 17 576 1.3× 414 1.5× 336 1.2× 373 1.8× 336 2.5× 41 1.1k
Tereza Kobrlová Czechia 13 176 0.4× 97 0.3× 101 0.4× 78 0.4× 47 0.4× 24 368

Countries citing papers authored by Eva Mezeiová

Since Specialization
Citations

This map shows the geographic impact of Eva Mezeiová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Mezeiová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Mezeiová more than expected).

Fields of papers citing papers by Eva Mezeiová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Mezeiová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Mezeiová. The network helps show where Eva Mezeiová may publish in the future.

Co-authorship network of co-authors of Eva Mezeiová

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Mezeiová. A scholar is included among the top collaborators of Eva Mezeiová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Mezeiová. Eva Mezeiová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mezeiová, Eva, Lukáš Prchal, Martina Hrabinová, et al.. (2024). Morphing cholinesterase inhibitor amiridine into multipotent drugs for the treatment of Alzheimer's disease. Biomedicine & Pharmacotherapy. 173. 116399–116399. 12 indexed citations
3.
Hepnarová, Vendula, Martina Hrabinová, Ľubica Múčková, et al.. (2022). Non-covalent acetylcholinesterase inhibitors: In vitro screening and molecular modeling for novel selective insecticides. Toxicology in Vitro. 85. 105463–105463. 5 indexed citations
4.
Górecki, Lukáš, Elisa Uliassi, Manuela Bartolini, et al.. (2021). Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer’s Disease. ACS Chemical Neuroscience. 12(9). 1698–1715. 19 indexed citations
5.
Pasieka, Anna, Dawid Panek, Jakub Jończyk, et al.. (2021). Discovery of multifunctional anti-Alzheimer’s agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and γ-aminobutyric acid transporters. European Journal of Medicinal Chemistry. 218. 113397–113397. 16 indexed citations
6.
Kello, Martin, Peter Takáč, Miroslava Martinková, et al.. (2021). Jaspine B Hydrochloride-induced Apoptosis in HeLa Cells Is Associated With Disrupted Sphingolipid Metabolism and Ceramide Overload. Anticancer Research. 41(6). 2875–2883. 5 indexed citations
7.
Mezeiová, Eva, Martina Hrabinová, Vendula Hepnarová, et al.. (2021). Huprine Y – Tryptophan heterodimers with potential implication to Alzheimer’s disease treatment. Bioorganic & Medicinal Chemistry Letters. 43. 128100–128100. 8 indexed citations
8.
Štefková, Kristýna, Wim Dehaen, Alena Randáková, et al.. (2021). Synthesis and In Vitro Evaluation of Novel Dopamine Receptor D2 3,4-dihydroquinolin-2(1H)-one Derivatives Related to Aripiprazole. Biomolecules. 11(9). 1262–1262. 4 indexed citations
9.
Mezeiová, Eva, Jana Janočková, Rudolf Andrýs, et al.. (2020). 2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer’s disease. European Journal of Medicinal Chemistry. 211. 113112–113112. 25 indexed citations
10.
Mezeiová, Eva, et al.. (2020). Recent advances with 5‐HT3 modulators for neuropsychiatric and gastrointestinal disorders. Medicinal Research Reviews. 40(5). 1593–1678. 39 indexed citations
11.
Mezeiová, Eva, Jana Janočková, Jan Konečný, et al.. (2020). From orexin receptor agonist YNT-185 to novel antagonists with drug-like properties for the treatment of insomnia. Bioorganic Chemistry. 103. 104179–104179. 5 indexed citations
12.
Svobodová, Barbora, Eva Mezeiová, Vendula Hepnarová, et al.. (2019). Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase Inhibitors. Biomolecules. 9(8). 379–379. 25 indexed citations
13.
Mezeiová, Eva, Eugenie Nepovimová, Lukáš Górecki, et al.. (2019). Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease. Current Alzheimer Research. 16(9). 772–800. 23 indexed citations
14.
Mezeiová, Eva, Katarína Špilovská, Eugenie Nepovimová, et al.. (2018). Profiling donepezil template into multipotent hybrids with antioxidant properties. Journal of Enzyme Inhibition and Medicinal Chemistry. 33(1). 583–606. 56 indexed citations
15.
Karasová, Jana Žďárová, et al.. (2018). 1-Benzyl-4-methylpiperidinyl moiety in donepezil: The priority ticket across the blood-brain-barrier in rats. Journal of Chromatography B. 1092. 350–358. 7 indexed citations
16.
Hepnarová, Vendula, Jan Korábečný, Petr Jošt, et al.. (2018). The concept of hybrid molecules of tacrine and benzyl quinolone carboxylic acid (BQCA) as multifunctional agents for Alzheimer's disease. European Journal of Medicinal Chemistry. 150. 292–306. 53 indexed citations
17.
Špilovská, Katarína, Jan Korábečný, Vendula Šepsová, et al.. (2017). Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer’s Agents: Design, Synthesis and Biological Evaluation. Molecules. 22(6). 1006–1006. 35 indexed citations
18.
Holas, Ondřej, Jan Korábečný, Zuzana Gažová, et al.. (2017). Alzheimer's Disease Drugs- In Vitro Comparison of Cholinesterase Inhibition and beta-amyloid Modulation. Letters in Drug Design & Discovery. 14(6).
19.
Špilovská, Katarína, Jan Korábečný, Eugenie Nepovimová, et al.. (2016). Multitarget Tacrine Hybrids with Neuroprotective Properties to Confront Alzheimer’s Disease. Current Topics in Medicinal Chemistry. 17(9). 1006–1026. 71 indexed citations
20.
Korábečný, Jan, Martin Andrš, Eugenie Nepovimová, et al.. (2015). 7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer’s Disease Treatment. Molecules. 20(12). 22084–22101. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ümide Demir Özkay Breakdown of academic impact, for papers by Mohamed Benchekroun Breakdown of academic impact, for papers by Santosh Kumar Prajapati Breakdown of academic impact, for papers by María Isabel Fernández‐Bachiller Breakdown of academic impact, for papers by Adrian Podkowa Breakdown of academic impact, for papers by Preet Anand Breakdown of academic impact, for papers by Monika Marcinkowska Breakdown of academic impact, for papers by M. Victòria Clos Breakdown of academic impact, for papers by Jakub Jończyk Breakdown of academic impact, for papers by Tereza Kobrlová
Rankless by CCL
2026